With over 60 commercial occupiers on campus, in addition to the Babraham Institute and wider Babraham Research Campus teams, there are generally a number of roles being advertised at any one time. Details of current vacancies are listed below, click on the links to discover more about them and how to apply.
Mission Therapeutics is an early-stage drug development company targeting the ubiquitin pathway for the treatment of neurodegenerative disease, rare mitochondrial diseases and fibrosis. The Company has built a leading platform for the discovery and development of first-in-class, small molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging drug class that is attracting significant commercial interest in the area of protein homeostasis.
Mission Therapeutics is a drug discovery and development company focused on the inhibition of deubiquitylating (DUB) enzymes for treatment of diseases with high unmet need including rare mitochondrial disorders, cancer, inflammation, and neurodegeneration. The company has established a widely-applicable and proprietary DUB research platform to enable the discovery of first in class drugs.
PolyProx Therapeutics is a spin-out from Cambridge University, Department of Pharmacology, based on exciting discoveries in the PROTACs/proteasome field and we are currently seeking enthusiastic and ambitious Research Scientists and Associates to join our dynamic team. The company will discover and develop a new class of drugs for the treatment of cancer, using novel engineered proteins that are able to selectively target tumour cells and trigger natural degradation machinery within the cell. This approach promises to address cancer targets that have proved intractable using current technologies, important in major diseases such as lung, colorectal and pancreatic cancers. PolyProx, based in R&D laboratories on the Babraham Research Campus, has raised seed financing of £3.4m to build and validate a drug discovery pipeline for several cancer drug targets.
PolyProx Therapeutics is a spin-out from Cambridge University, Department of Pharmacology, based on exciting discoveries in the PROTACs/proteasome field and we are currently seeking enthusiastic and ambitious Research Scientists and Associates to join our dynamic team. The company will discover and develop a new class of drugs for the treatment of cancer, using novel engineered proteins that are able to selectively target tumour cells and trigger natural degradation machinery within the cell. This approach promises to address cancer targets that have proved intractable using current technologies, important in major diseases such as lung, colorectal and pancreatic cancers. PolyProx, based in R&D laboratories on the Babraham Research Campus, has raised seed financing of £3.4m to build and validate a drug discovery pipeline for several cancer drug targets.
F-STAR is committed to delivering life-changing treatments to cancer patients. We develop mAb², a novel class of disruptive bispecific antibody-based therapy that have the potential to overcome tumour resistance and restore anti-cancer immunity and responsiveness. We are currently looking for an experienced Project Manager to manage the delivery of all aspects of a clinical project, working closely with key clinical, translational, manufacturing & supply, medical and research functions, as well as third-party providers.
Position provides an excellent opportunity to develop your skills and gain new experience in a small team which is growing in significance within the company, for these roles, you will need to be able to independently design and carry out routine experiments. You will have the opportunity to contribute to the planning and development of complex experiments and investigate new techniques.
Position provides an excellent opportunity to develop your skills and gain new experience in a small team which is growing in significance within the company, for these roles, you will need to be able to independently design and carry out routine experiments. You will have the opportunity to contribute to the planning and development of complex experiments and investigate new techniques.
A leader in the restoration of tissue function, Videregen is a clinical stage company with an initial focus on airway diseases. It is using its proprietary tissue processing technology to develop high quality standardised tissue restoration products which it will bring to market in countries across the world.
This is an exciting time for the company as it expands its pipeline and international presence, and Videregen’s ambitious and entrepreneurial team is now looking to recruit a product development scientist.
F-star is looking for a software developer to take on a new key role in delivering efficient and robust data solutions to use across all R&D activities at F-star. The successful candidate will be responsible for designing, integrating with current systems, and implementing database solutions within R&D to allow Scientists to generate, analyse, and interrogate large amounts of data.
Working within the Protein Sciences group, you will proactively contribute to the development and delivery of analytical capabilities to support our technology platform and mAb2 bispecific pipeline. Analytical capabilities are required to deliver protein engineering, research grade production and process development activities with a key focus on protein characterisation and developability assessments.
The Research Associate will work within the Preclinical Translational Pharmacology (PTP) Department and be responsible for supporting and enhancing cell culture capabilities within PTP and across F-Star. In this position, the candidate will also contribute to developing and characterising preclinical models, to aid our understanding of the mechanism of our drug candidates and support F-Star preclinical capabilities.
At F-star, we are committed to delivering life-changing treatments to cancer patients. We develop mAb², a novel class of disruptive bispecific antibody-based therapy that have the potential to overcome tumour resistance and restore anti-cancer immunity and responsiveness.
In this newly created role, the Director, Translational Medicine will form an important part of the scientific and clinical leadership team, working closely with the CMO and CSO, the incumbent will be pivotal in strengthening the quality and progress of F-star’s crucial clinical and translational medicine input to early stage R&D projects to achieve key milestones.
F-star is looking for a software developer to take on a new key role in delivering efficient and robust data solutions to use across all R&D activities at F-star. The successful candidate will be responsible for designing, integrating with current systems, and implementing database solutions within R&D to allow Scientists to generate, analyse, and interrogate large amounts of data.
The senior research associate will undertake a laboratory based role within our Protein Sciences group, responsible for protein purification and subsequent characterisation of antigens, antibody fragments and mAb2 molecules as well as identifying and leading improvements to F-star purification technologies.
These roles will contribute to the validation and understanding of target biology. In the positions the successful applicants will identify protein interactors as well as substrates with the aim of understanding modulation of disease relevant pathways.
PredictImmune is a spin-out from Cambridge University and is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis).
With continued growth, we are now seeking a Scientist/Senior Scientist.
(+44) 1223 496 000
info@babraham.co.uk
Babraham Bioscience Technologies Ltd
Babraham Research Campus
Cambridge
CB22 3AT, United Kingdom
Limewash
01223 813 557
info@limewash.co.uk
